Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001455244-10-000027)

Filing Details

Accession Number:: 0001455244-10-000027
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2010-01-12 12:00:00
Reporting Period:: 2010-01-07

Filing Date:: 2010-01-12
Accepted Time:: 2010-01-12 15:36:18
Original Submission Date:: 2010-01-11
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1278129	Osteologix Inc.	OLGX OB	Pharmaceutical Preparations (2834)	320104570

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1360509	Florian Schonharting	Ostergade 5, 3Rd Floor, Dk-1100 Copenhagen K G7		No	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2010-01-07	1,992,428	$0.50	5,022,732	No	4	P	Indirect	By Nordic Biotech Opportunity Fund K/S

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Indirect	By Nordic Biotech Opportunity Fund K/S

Footnotes

The price was misstated on the Reporting Person's original Form 4 filed January 11, 2010 and has been corrected in this amendment.
Mr. Sch?nharting is a principal of Nordic Biotech Opportunity Fund K/S, which is the record holder of 5,022,732 shares of Common Stock. Mr. Sch?nharting disclaims beneficial ownership of the securities held by Nordic Biotech Opportunity Fund K/S, except to the extent of his pecuniary interest therein.